8-cyclopentyl-1,3-dimethylxanthine has been researched along with pk 11195 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| MacGregor, DG; Miller, WJ; Stone, TW | 1 |
2 other study(ies) available for 8-cyclopentyl-1,3-dimethylxanthine and pk 11195
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Mediation of the neuroprotective action of R-phenylisopropyl-adenosine through a centrally located adenosine A1 receptor.
Topics: Animals; Clonazepam; Hippocampus; Isoquinolines; Kainic Acid; Male; Neurons; Phenylisopropyladenosine; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, Purinergic P1; Theophylline | 1993 |